Compare EVAX & FUSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVAX | FUSE |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9M | 28.6M |
| IPO Year | 2020 | 2025 |
| Metric | EVAX | FUSE |
|---|---|---|
| Price | $3.24 | $0.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $11.67 | N/A |
| AVG Volume (30 Days) | 11.4K | ★ 3.4M |
| Earning Date | 05-07-2026 | 06-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 96.38 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,714,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $328.20 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.52 | $0.75 |
| 52 Week High | $12.15 | $3.67 |
| Indicator | EVAX | FUSE |
|---|---|---|
| Relative Strength Index (RSI) | 61.23 | 44.97 |
| Support Level | $2.93 | $0.82 |
| Resistance Level | $3.61 | $1.93 |
| Average True Range (ATR) | 0.16 | 0.17 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 83.61 | 8.23 |
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.
Fusemachines Inc is a provider of enterprise AI solutions, offering products such as AI Studio, AI Engines, and AI Agents, along with supporting services across various industries. Its solutions are supported by a talent pool from underserved communities, enabling scalable and high-quality AI delivery while promoting access to AI. The Company serves clients across industries, including healthcare, media, technology, and government, helping address challenges such as improving forecasting accuracy, reducing data entry errors, automating recruitment, and detecting fraud. Its product suite includes AI Studio, AI Engines, and AI Agents, designed to build, deploy, and scale AI solutions, and it operates in Nepal and the United States.